Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15247437.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe the efficacy of L-870812, an inhibitor of HIV-1 and SIV integrase, in rhesus macaques infected with the simian-human immunodeficiency virus (SHIV) 89.6P. When initiated before CD4 cell depletion, L-870812 therapy mediated a sustained suppression of viremia, preserving CD4 levels and permitting the induction of virus-specific cellular immunity. L-870812 was also active in chronic infection; however, the magnitude and durability of the effect varied in conjunction with the pretreatment immune response and viral load. These studies demonstrate integrase inhibitor activity in vivo and suggest that cellular immunity facilitates chemotherapeutic efficacy in retroviral infections.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- HIV-1
- Integrase Inhibitors
- Naphthyridines
- Simian Acquired Immunodeficiency Syndrome
- Simian Immunodeficiency Virus